Status: current, Defined. Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3013470014 | Retigabine (product) | en | Fully specified name | Inactive | Initial character case insensitive | SNOMED CT core |
| 3013529010 | Retigabine | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3286225015 | Ezogabine | en | Synonym | Inactive | Initial character case insensitive | SNOMED CT core |
| 3488422013 | Product containing retigabine (medicinal product) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3497301019 | Product containing retigabine | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3669130014 | Retigabine product | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3716457018 | Retigabine-containing product | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Retigabine-containing product | Is a | Nitrogen and/or nitrogen compound-containing product | true | Inferred relationship | Some | ||
| Retigabine-containing product | Is a | Medicinal product categorised by disposition | false | Inferred relationship | Some | ||
| Retigabine-containing product | Is a | Carbamate-containing product | true | Inferred relationship | Some | ||
| Retigabine-containing product | Is a | Potassium channel activator-containing product | true | Inferred relationship | Some | ||
| Retigabine-containing product | Plays role | Anticonvulsant therapeutic role | true | Inferred relationship | Some | ||
| Retigabine-containing product | Is a | Anticonvulsant agent | true | Inferred relationship | Some | ||
| Retigabine-containing product | Has active ingredient | Retigabine | true | Inferred relationship | Some | 1 | |
| Retigabine-containing product | Is a | Medicinal product | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Retigabine only product | Is a | True | Retigabine-containing product | Inferred relationship | Some | |
| Retigabine 300 mg oral tablet | Is a | False | Retigabine-containing product | Inferred relationship | Some | |
| Retigabine 400 mg oral tablet | Is a | False | Retigabine-containing product | Inferred relationship | Some | |
| Retigabine 200 mg oral tablet | Is a | False | Retigabine-containing product | Inferred relationship | Some | |
| Retigabine 100 mg oral tablet | Is a | False | Retigabine-containing product | Inferred relationship | Some | |
| Retigabine 50 mg oral tablet | Is a | False | Retigabine-containing product | Inferred relationship | Some | |
| Retigabine-containing product in oral dose form | Is a | True | Retigabine-containing product | Inferred relationship | Some |
This concept is not in any reference sets
FHIR